Scientific Industries(SCND)

Focus: Scientific Industries is a public biotechnology company specializing in lab equipment, headquartered in Bohemia, NY. The company operates as a niche player in the life sciences instrumentation sector.

Profile data last refreshed 6h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Scientific Industries

AI assessmentNot Hiring

No open roles listed right now. Follow Scientific Industries to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$5M

FY2025

Pipeline & Clinical Trials

Albendazole

Infections With Soil-Transmitted Helminths (STH)

Phase 4

Clinical Trials (1)

NCT01087099A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children

Phase 4

Help build intelligence for Scientific Industries

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

60% R&D intensity signals commitment to innovation and product development
Public company status provides equity upside and career mobility
Niche lab equipment focus offers specialized technical expertise opportunities

Watch Out For

Revenue declined 55% YoY ($11M to $5M) with worsening net losses ($9.1M to $6.4M), indicating severe commercial headwinds
Zero active job openings and no disclosed hiring activity suggest organizational contraction or frozen growth
Minimal pipeline (1 Phase 4 program in parasitic infections) indicates limited product diversification or innovation momentum

Generated by Claude from Scientific Industries's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

SEC Filings: 2 available

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Financials (FY2025)

Revenue

$5M57%

R&D Spend

$3M(60%)19%

Net Income

-$6M

Source: SEC 10-K Filing